These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8996641

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats.
    Kusunoki M, Tsutsumi K, Inoue Y, Hara T, Miyata T, Nakamura T, Ogawa H, Sakakibara F, Fukuzawa Y, Okabayashi N, Kato K, Ikeda H, Kurokawa T, Ishikawa T, Otake K, Nakaya Y.
    Metabolism; 2004 Feb; 53(2):260-3. PubMed ID: 14767881
    [Abstract] [Full Text] [Related]

  • 4. Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats.
    Tsutsumi K, Inoue Y, Shima A, Murase T.
    Diabetes; 1995 Apr; 44(4):414-7. PubMed ID: 7698509
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined effect of vitamin E and insulin on cataracts of diabetic rats fed a high cholesterol diet.
    Yoshida M, Kimura H, Kyuki K, Ito M.
    Biol Pharm Bull; 2004 Mar; 27(3):338-44. PubMed ID: 14993799
    [Abstract] [Full Text] [Related]

  • 8. Hyperlipidemia in streptozocin-diabetic hamsters as a model for human insulin-deficient diabetes: comparison to streptozocin-diabetic rats.
    Ebara T, Hirano T, Mamo JC, Sakamaki R, Furukawa S, Nagano S, Takahashi T.
    Metabolism; 1994 Mar; 43(3):299-305. PubMed ID: 8139477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.
    Higashi Y, Higashi K, Mori A, Sakamoto K, Ishii K, Nakahara T.
    Biol Pharm Bull; 2018 Mar; 41(10):1586-1592. PubMed ID: 30270328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
    Kusunoki M, Tsutsumi K, Hara T, Ogawa H, Nakamura T, Miyata T, Sakakibara F, Fukuzawa Y, Suga T, Kakumu S, Nakaya Y.
    Metabolism; 2002 Jun; 51(6):792-5. PubMed ID: 12037738
    [Abstract] [Full Text] [Related]

  • 16. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats.
    Anandh Babu PV, Sabitha KE, Shyamaladevi CS.
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499
    [Abstract] [Full Text] [Related]

  • 17. Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins.
    Yu T, Sungelo MJ, Goldberg IJ, Wang H, Eckel RH.
    Horm Metab Res; 2017 May; 49(5):400-406. PubMed ID: 28395380
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [On the etiology of diabetic hyperlipidemia from the aspects of the metabolism of ApoHDL (author's transl)].
    Keimatsu M.
    Hokkaido Igaku Zasshi; 1981 Sep; 56(5):557-69. PubMed ID: 7319464
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.